Masashi Takizawa - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Masashi Takizawa

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Toxicology Letters|May 23, 2020

Decrease in ADAR1 expression by exposure to cigarette smoke enhances susceptibility to oxidative stressMasashi Takizawa, Masataka Nakano, Tatsuki Fukami, et al.

Toxicology in Vitro : an International Journal Published in Association with BIBRA|October 24, 2006

Paraquat-induced oxidative stress and dysfunction of cellular redox systems including antioxidative defense enzymes glutathione peroxidase and thioredoxin reductaseMasashi Takizawa, Kumiko Komori, Yoshiko Tampo, et al.

Dermatology and Therapy|May 15, 2026

Machine-Learning-Based Prediction of Long-Term Efficacy of Nemolizumab: Post Hoc Analysis of Pooled Data from Two Phase III Clinical TrialsMakoto Kawashima, Tomoya Maeda, Kotaro Iwasaki, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Toxicology Letters|May 23, 2020

Decrease in ADAR1 expression by exposure to cigarette smoke enhances susceptibility to oxidative stressMasashi Takizawa, Masataka Nakano, Tatsuki Fukami, et al.

Toxicology in Vitro : an International Journal Published in Association with BIBRA|October 24, 2006

Paraquat-induced oxidative stress and dysfunction of cellular redox systems including antioxidative defense enzymes glutathione peroxidase and thioredoxin reductaseMasashi Takizawa, Kumiko Komori, Yoshiko Tampo, et al.

Dermatology and Therapy|May 15, 2026

Machine-Learning-Based Prediction of Long-Term Efficacy of Nemolizumab: Post Hoc Analysis of Pooled Data from Two Phase III Clinical TrialsMakoto Kawashima, Tomoya Maeda, Kotaro Iwasaki, et al.

Pageof 1